AMERGE is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Glaxosmithkline Llc. The primary component is Naratriptan Hydrochloride.
Product ID | 0173-0562_5b76fec2-b609-4a83-8276-412205c701f1 |
NDC | 0173-0562 |
Product Type | Human Prescription Drug |
Proprietary Name | AMERGE |
Generic Name | Naratriptan Hydrochloride |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 1998-02-26 |
Marketing Category | NDA / NDA |
Application Number | NDA020763 |
Labeler Name | GlaxoSmithKline LLC |
Substance Name | NARATRIPTAN HYDROCHLORIDE |
Active Ingredient Strength | 3 mg/1 |
Pharm Classes | Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 1998-02-26 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020763 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1998-02-26 |
Marketing Category | NDA |
Application Number | NDA020763 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2009-10-31 |
Marketing End Date | 2013-03-04 |
Ingredient | Strength |
---|---|
NARATRIPTAN HYDROCHLORIDE | 2.5 mg/1 |
SPL SET ID: | 13f4a8ec-75a3-4c51-b3bc-6244f3c79e95 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0173-0561 | AMERGE | naratriptan hydrochloride |
0173-0562 | AMERGE | naratriptan hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
AMERGE 98069353 not registered Live/Pending |
Amerge, LLC 2023-07-03 |
AMERGE 78027114 2480159 Dead/Cancelled |
Amerge Corporation 2000-09-21 |
AMERGE 75165466 2170207 Live/Registered |
GLAXO GROUP LIMITED 1996-09-13 |